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Background: Metabolic syndrome (MetS), associated with the risk of cardiovascular disease and stroke,
resulted in subsequent functional decline among aging population. It would be of interest to investigate
the characteristics and related health behaviors of MetS among community-dwelling elderly.
Methods: During 2007e2010, we selected the elderly who underwent the annual health checkup and
screen in Taipei Veterans General Hospital and did not have MetS in their ﬁrst year of participation as the
study population. After a mean of 2.8 years’ follow-up, the elderly were categorized into new-developed
MetS patients and non-MetS patients according to Adult Treatment Panel III diagnostic criteria of MetS.
Health behaviors were collected using a questionnaire and the laboratory data were analyzed.
Results: A total of 888 community-dwelling elderly were enrolled. Of those participants, 206 (23.2%)
developed MetS (new-developed MetS group) and 682 (76.8%) did not develop MetS (non-MetS group).
Presence of higher initial MetS score, hyperuricemia, and proteinuria, and lack of exercise were associ-
ated with new-developed MetS in the elderly. Proteinuria and initial MetS score of two patients were
signiﬁcantly related to the development of MetS in the Cox regression analysis (hazard ratio 2.530 and
4.728, respectively). Other health behaviors such as smoking, alcohol drinking, teeth brushing, vegetable
intake, and milk intake were not correlated signiﬁcantly with the development of MetS.
Conclusion: For the community-dwelling elderly, proteinuria and initial MetS score of two participants
were correlated to the occurrence of MetS. A stricter control of risk factors of MetS in these elderly is
necessary.
Copyright  2012, Taiwan Society of Geriatric Emergency & Critical Care Medicine. Published by Elsevier
Taiwan LLC. All rights reserved.1. Introduction
Metabolic syndrome (MetS), also called "Syndrome X,"l "deadly
quartet,"2 and "insulin-resistance syndrome,"3 is a cluster of
interacting metabolic risk factors including dyslipidemia, insulin
resistance, hyperglycemia, increased blood pressure, and abdom-
inal obesity4. MetS was proved to increase the risks of diabetes,
cardiovascular disease, cerebrovascular disease, and all-cause
mortality5. Each of cardiovascular and cerebrovascular diseaseserest.
Department of Family Medi-
tion 2, Shih-Pai Road, Taipei
ng).
iwan Society of Geriatric Emergenwas one of the top 10 leading causes of death, being only inferior to
malignancy in Taiwan6. Among the elderly population, MetS not
only predicts the cardiovascular disease mortality and stroke7,8, but
also leads to mobility decline of community-dwelling older
people9. MetS results in a substantial healthcare economic burden
and is an important medical issue in the aging society10.
Park et al11 reported that higher body mass index (BMI), current
smoking, low household income, high carbohydrate intake, no
alcohol consumption, and physical inactivity were risk factors
associated with MetS in the United States. Otsuka and his
colleagues found that lower intake of calcium, milk, and dairy
products, and gingival inﬂammation were related to MetS12,13. In
Taiwan, Chen et al14 reported that smoking was associated with
MetS as well as its individual components. However, most studies
investigating the features and health behaviors of MetS focused on
adults. Little longitudinal studies mainly talked about the elderly.cy & Critical Care Medicine. Published by Elsevier Taiwan LLC. All rights reserved.
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teristics and health behaviors of community-dwelling elderly with
newly developed MetS during a 4-year follow-up in Taipei city in
Taiwan.
2. Materials and methods
2.1. Data source
Data were obtained from annual health checkup and screen for
the elderly in Taipei Veterans General Hospital during 2007e2010.
The annual health checkup for the community-dwelling elderly
aged 65 years and above was provided by the Bureau of Health
Promotion of Department of Health and the Taipei city government.
The contents of the health checkup and screen included records,
collected using a questionnaire, of the past medical histories and
health behaviors such as the habits of smoking, drinking, and
exercise. The health checkup also contained the measurements of
height, body weight, waist circumference, and blood pressure, and
result of physical examinations. Biochemistry laboratory examina-
tions included the estimation of serum total cholesterol, triglyc-
eride (TG), high-density lipoprotein cholesterol (HDL-C), fasting
glucose, alanine aminotransferase (ALT), creatinine, and uric acid,
and urine analysis.
The elderly who satisﬁed with the diagnostic criteria of MetS at
their ﬁrst health checkup were excluded. Only those who did not
have MetS in their ﬁrst year of participation were enrolled. We
divided the participants into new-developed metabolic syndrome
(new-developed MetS) group and nonmetabolic syndrome (non-
MetS) group. Individuals who satisﬁed the Adult Treatment Panel
III (ATP III)diagnostic criteria15,16 of MetS during the follow-up time
frame were categorized as new-developed MetS patients, while
those who did not satisfy the ATP III diagnostic criteria of MetS
during the study period were categorized as non-MetS patients.
2.2. Variable deﬁnition
For each participant, we calculated the initial MetS score
according to their ﬁrst health checkup data. The initial MetS score
was the numbers of positive MetS components. Measurements of
body height, body weight, and waist circumference were carried
out by well-trained nurses. The waist circumference was measured
at the midpoint between the lower border of the rib cage and the
iliac crest. BMI is calculated as individual’s body weight divided by
the square of his or her height (kg/m2). According to the BMI
classiﬁcation of the Bureau of Health Promotion in Taiwan17, indi-
viduals with a BMI of <18.5 were categorized as underweight,
18.5e23.9 as normal, 24e26.9 as overweight, and 27 as obese.
Laboratory data were analyzed in the central laboratory of Taipei
Veterans General Hospital. Serum TG, HDL-C, fasting glucose,
creatinine, ALT, uric acid, and urine protein were analyzed by the
automatic analyzer (Hitachi Model 736, Tokyo, Japan), and the
urine dipstick test were analyzed by the automated urine chemistry
analyzer (Siemens Clinitek Atlas, Munich, Germany). The results as
"e", "", "þ" represented negative, trace positive, and >30 mg/dL,
respectively. Hyperuricemia was deﬁned as serum uric acid level
7.0 mg/dL for men or 6.0 mg/dL for women18.
We obtained the information on medical histories and health
behaviors by personal interview using the questionnaires,
including the histories of hypertension, diabetes mellitus, and
hyperlipidemia under long-term medication as well as the health
behaviors of smoking, alcohol drinking, exercise, vegetable intake,
milk intake, and teeth brushing. The habits of smoking and alcohol
drinking were deﬁned as the exposer of the patient to the above
substances within 6 months prior to the survey. Milk intake wasdeﬁned as drinking milk every day. If the participants took three
dishes of vegetable and two kinds of fruit every day, he or she
would be classiﬁed as a vegetable-intake individual. Exercise was
deﬁned as continuing exercise for more than 20 minutes each time
and coded as "no exercise," "occasional exercise” (exercising less
than three times a week), and "frequent exercise” (exercising more
than three times a week).” Teeth brushing was categorized as "no,"
"in the morning and prior to sleep," and "in the morning, after
meals, and prior to sleep".
2.3. Diagnostic criteria for MetS
In 2001, the National Cholesterol Education Program (NCEP) ATP
III used the following criteria for the diagnosis of MetS: abdominal
obesity (deﬁned as waist circumference in men 102 cm and in
women 88 cm), high serum TG level (150 mg/dL), low serum
HDL-C level (<40 mg/dL), high blood pressure (130/85 mmHg) or
drug treatment for elevated blood pressure, and high fasting
plasma glucose (110 mg/dL) or receiving drug treatment for
elevated blood sugar15,16. The NCEPATP III lowered the threshold of
abnormal fasting glucose to 100 mg/dL for the early detection of
impaired fasting glucose, as well as in accordance with the deﬁni-
tion of American Diabetes Association19. As the body composition
was different among ethics, abdominal obesity for Asians was
deﬁned as waist circumference 90 cm for men and 80 cm for
women by International Diabetes Foundation19,20. In this study, the
diagnostic criteria for MetS include the following: (1) Waist
circumference 90 cm for men and 80 cm for women; (2) serum
TG150mg/dL; (3) serum HDL<40 mg/dL for men and<50 mg/dL
for women; (4) blood pressure 130/85 mmHg or hypertension on
medication; and (5) fasting glucose 100 mg/dL or diabetes mel-
litus on medication.
Participants who satisﬁed three or more items of the diagnostic
criteria were deﬁned as having MetS.
2.4. Statistical analysis
Data in the text and tables were expressed as mean  standard
deviation (SD). We used SPSS version 17.0 (SPSS Inc., Chicago, IL,
USA) for statistical analysis in this study. The categorical variables
including gender, history of hypertension, diabetes mellitus, and
hyperuricemia between the new-developed MetS and the non-
MetS patients were compared by using chi-square tests. The
numerical variables including mean age, initial MetS score, BMI,
systolic and diastolic blood pressures, serum TG levels, HDL-C
levels, fasting glucose levels, serum creatinine, ALT, and uric acid
levels were compared by using Student t test between both the
groups. Because participants might have different period of follow-
up in our study, we used Cox regression to investigate the possible
risk factors of new-developedMetS. Serum creatinine, ALT, and uric
acid level were included as continuous variables in the regression
model. Age, gender, initial MetS score, smoking, drinking, exercise,
vegetable intake, milk intake, and teeth brushing were included as
categorical variables. A p value of <0.05 (two-tailed) was consid-
ered as statistically signiﬁcant. For each signiﬁcant factor,
KaplaneMeier curve was provided for the comparison of free-
from-MetS status. The signiﬁcance of the differences among the
KaplaneMeier curves was examined by log-rank test.
3. Results
3.1. Demographic characteristics
A total of 888 community-dwelling elderly were enrolled.
During a mean of 2.8 years’ follow up, 206 (23.2%) patients
Yi-H. Lin et al.92developed MetS and 682 (76.8%) did not develop MetS (Table 1).
New-developed MetS patients had a signiﬁcantly higher
percentage of histories of hypertension and diabetes mellitus than
non-MetS patients (59.7% vs. 33.8% and 21.8% vs. 5.3%, respectively;
both p< 0.001). New-developed MetS elderly also had signiﬁcantly
higher mean BMI, waist circumference, and initial MetS score than
non-MetS patients(24.9  2.9 vs. 22.3  2.6, 90.5  7.0 vs.
80.6  8.2, and 1.8  0.4 vs. 1.5  0.6, respectively; all p < 0.001).Fig. 1. The percentage of the patients with new-developed MetS among male and
female elderly in different age groups.
Table 2
Clinical and laboratory measurements of community-dwelling elderly joining
annual health checkup and screen from 2007 to 2010.3.2. Age and gender difference for the development of MetS
Fig. 1 showed the differences of the rate of new-developed MetS
between male and female elderly in different age groups. After
a mean of 2.8 years’ follow-up, the rate of new-developedMetS was
23.2% among the total 888 elderly. The rate of new-developed MetS
was 25.9% among female elderly, which was decreasing with age
(15.7%, 8.7%, and 1.4% in 65e74-year group, 75e84-year group, and
85-year group, respectively). The rate of new-developed MetS
among male elderly was 21.9% and reached a peak at the age of
75e84 years (15.8%).New-developed MetS Non-MetS p
n (%) n (%)
Systolic BP (mmHg)
Mean  SD 134.7  14.1 128.6  15.2 <0.001
<130 61 (29.6) 366 (54.1) <0.001
130e139 69 (33.5) 153 (22.6)
140e159 68 (33.0) 141 (20.8)
160 8 (3.9) 17 (2.5)
Diastolic BP (mmHg)
Mean  SD 75.4  9.5 73.6  9.3 0.027
<85 169 (82.0) 605 (89.4) 0.0163.3. Clinical and laboratory measurements
The means of systolic blood pressure, diastolic blood pressure,
serum TG levels, and fasting glucose levels were signiﬁcantly
higher in the new-developed MetS group than in the non-MetS
group (134.7  14.1 vs. 128.6  15.2 mmHg, 75.4  9.5 vs.
73.6  9.3 mmHg, and 134.4  73.9vs. 84.9  43.4 mg/dL,
109.7  30.0vs. 95.1  12.8 mg/dL, respectively; all p < 0.001)
(Table 2). The proportion of the elderly with high fasting bloodTable 1
Demographic characteristic of community-dwelling elderly joining annual health
checkup and screen from 2007 to 2010.
New-developed MetS Non-MetS p
n (%) n (%)
Age (y)
Mean  SD 77.0  5.9 76.0  6.1 0.031
65e74 66 (32) 261 (38.3) 0.174
75e84 120 (58.3) 373 (54.7)
85 20 (9.7) 48 (7.0)
Gender
Male 132 (64.1) 470 (68.9) 0.193
Female 74 (35.9) 212 (31.1)
History of HTN 123 (59.7) 230 (33.8) <0.001
History of DM 45 (21.8) 36 (5.3) <0.001
History of hyperlipidemia 21 (10.2) 59 (8.7) 0.498
BMI (kg/m2)
Mean  SD 24.9  2.9 22.3  2.6 <0.001
<18.5 0 (0) 47 (6.9) <0.001
18.5e23.9 82 (39.8) 463 (67.9)
24e26.9 83 (40.3) 147 (21.6)
27 41 (19.9) 25 (3.7)
Waist circumference (cm)
Mean  SD 90.5  7.0 80.6  8.2 <0.001
Waist circumference (cm)/height (cm)
Mean  SD 0.56  0.04 0.50  0.05 <0.001
The initial MetS score
Mean  SD 1.8  0.4 1.5  0.6 <0.001
0 2 (1.0) 56 (8.2) <0.001
1 43 (20.9) 256 (37.5)
2 161 (78.2) 370 (54.3)
Total 206 (23.2) 682 (76.8)
BMI ¼ body mass index; DM ¼ diabetes mellitus; HTN ¼ hypertension;
MetS ¼ metabolic syndrome; SD ¼ standard deviation.
85e89 26 (12.6) 48 (7.1)
90e99 11 (5.3) 22 (3.2)
100 0 (0) 2 (0.3)
TG (mg/dL)
Mean  SD 134.4  73.9 84.9  43.4 <0.001
<150 132 (64.1) 654 (95.9) <0.001
150 74 (35.9) 28 (4.1)
HDL (mg/dL)
Mean  SD 50.2  13.5 63.4  15.3 <0.001
<40 in male 38 (23.9) 5 (1.0) <0.001
40 in male 47 (29.6) 306 (58.5)
<50 in female 24 (15.1) 17 (3.3)
50 in female 50 (31.4) 195 (37.3)
Fasting glucose (mg/dL)
Mean  SD 109.7  30.0 95.1  12.8 <0.001
<100 55 (26.7) 522 (76.5) <0.001
100e125 128 (62.1) 145 (21.3)
126 23 (11.2) 15 (2.2)
Serum creatinine (mg/dL)
Mean  SD 0.99  0.33 1.02  0.53 0.578
ALT (U/L)
Mean  SD 22.7  7.1 22.4  8.9 0.903
40 6 (2.9) 21 (3.1) 0.614
<40 200 (97.1) 661 (96.9)
Uric acid (mg/dL)
7.0 in male 41 (20.1) 109 (16.1) 0.005
<7.0 in male 89 (43.6) 357 (52.7)
6.0 in female 22 (10.8) 33 (4.9)
<6.0 in female 52 (25.5) 179 (26.4)
Proteinuria (mg/dL)
e 162 (79.0) 571 (84.7) 0.001
 22 (10.7) 79 (11.7)
þ 21 (10.2) 24 (3.6)
Total 206 (23.2) 682 (76.8)
ALT ¼ alanine aminotransferase; BP ¼ blood pressure; HDL ¼ high-density lipo-
protein; MetS ¼ metabolic syndrome; SD ¼ standard deviation; TG ¼ triglyceride.
Table 4
Cox regression analysis of risk factors for new-developed MetS among community-
dwelling elderly.
b SE p Hazard
ratio
95% CI
Age (y)
65e74 Reference
75e84 0.051 0.181 0.779 1.052 0.738e1.499
85 0.283 0.286 0.322 1.327 0.758e2.322
Gender
Male Reference
Female 0.228 0.197 0.248 1.256 0.853e1.850
Serum creatinine 0.498 0.348 0.153 0.608 0.307e1.203
ALT (U/L) 0.014 0.008 0.095 1.014 0.998e1.030
Uric acid (mg/dL) 0.085 0.051 0.094 1.088 0.986e1.202
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than that in the non-MetS group(73.3% vs. 23.5%; p < 0.001). About
40% of new-developed MetS patients had serum TG 150 mg/dL
and low HDL-C levels<40 mg/dL in male and<50 mg/dL in female,
while only about 4% of non-MetS elderly had the same abnormality
(both p < 0.001). The rate of proteinuria was higher in new-
developed MetS patients than in non-MetS patients (10.2% vs.
3.6%; p ¼ 0.001). The rate of hyperuricemia in both males and
females was also higher in the new-developed MetS group than in
the non-MetS group (p¼ 0.005). No signiﬁcant difference existed in
serum creatinine and ALT levels between the two groups
(0.99  0.33 vs. 1.02  0.53 mg/dL, and 22.7  7.1 vs. 22.48.9 U/L,
respectively; p ¼ 0.578 and 0.614, respectively).
3.4. Health behaviors
The percentage of the elderly who exercised more than three
times a week was signiﬁcantly higher in the non-MetS group than
in the new-developed MetS group (76.1% vs. 66.6%; p < 0.05)
(Table 3). The new-developed MetS elderly were more likely to
return for health checkup and screen than the non-MetS elderly
during the study period (3.1  0.8 vs. 2.7  0.8; p < 0.001).
Otherwise, the rate of other health behaviors, including smoking,
alcohol drinking, vegetable intake, milk intake, and teeth brushing,
were not signiﬁcantly different between the two groups (p¼ 0.582,
0.336, 0.355, 0.311, and 0.779, respectively).
3.5. Risk factors of new-developed MetS among community-
dwelling elderly
Cox regression analysis showed that the presence of proteinuria
and initial MetS score of 2 were signiﬁcant risk factors associated
with the development of MetS (hazard ratio 2.530, 95% CITable 3
Health behaviors in new-developed MetS and non-MetS groups.
New-developed
MetS
Non-MetS p
n (%) n (%)
Smoking
No 198 (96.6) 646 (95.0) 0.582
Social 2 (1.0) 13 (1.9)
Everyday 5 (2.5) 21 (3.1)
Drinking
No 155 (75.2) 476 (70.2) 0.336
Social 48 (23.3) 186 (27.4)
Frequent 3 (1.5) 16 (2.4)
Exercise
No 13 (6.4) 31 (4.6) 0.028
Occasional 55 (27.0) 131 (19.4)
Frequent 136 (66.6) 514 (76.1)
Vegetable intake 154 (75.1) 531 (78.2) 0.355
Milk intake 123 (59.7) 380 (55.7) 0.311
Teeth brushing
No 3 (1.5) 6 (0.9) 0.779
In the morning and prior to sleep 139 (67.5) 458 (68.2)
In the morning, after meals,
and prior to sleep
64 (31.1) 208 (31.0)
Frequency of follow-up
Mean  SD 3.1  0.8 2.7  0.8 <0.001
2 61 (29.6) 352 (51.6) <0.001
3 72 (35.0) 197 (28.9)
4 73 (35.4) 133 (19.5)
Total 206 (23.2) 682 (76.8)
MetS ¼ metabolic syndrome; SD ¼ standard deviation.1.521e4.208; p < 0.001 and hazard ratio 4.728, 95% CI
1.153e19.382; p ¼ 0.031, respectively) (Table 4). The elderly who
had proteinuria and higher initial MetS score would be more likely
to develop MetS than other participants (Figs. 2 and 3; p ¼ 0.001
and p < 0.001, respectively).4. Discussion
During 2007e2010, we found that about one-ﬁfth of the elderly
who joined the annual health checkup and screen in the Taipei
Veterans General Hospital developed MetS. The rate of new-
developed MetS varied for different ages and genders. The pres-
ence of proteinuria and initial MetS score of 2 were positive
predictive factors of new-developed MetS.
In our study, proteinuria was positively associated with new-
developed MetS. In Japan, Miyatake et al found that people with
MetS had a higher rate of proteinuria than those without MetS21,22.Urine protein
e Reference
 0.193 0.232 0.405 1.212 0.770e1.909
þ 0.928 0.260 <0.001 2.530 1.521e4.208
Initial MetS score
0 Reference
1 1.021 0.729 0.161 2.777 0.665e11.594
2 1.554 0.720 0.031 4.728 1.153e19.382
Smoking
No Reference
Social 0.148 0.176 0.401 0.862 0.610e1.218
Everyday 1.467 1.022 0.151 0.231 0.031e1.709
Drinking
No Reference
Social 0.148 0.176 0.401 0.862 0.610e1.218
Frequent 1.467 1.022 0.151 0.231 0.031e1.709
Exercise
No Reference
Occasional 0.129 0.320 0.686 0.879 0.469e1.645
Frequent 0.519 0.304 0.088 0.595 0.328e1.081
Vegetable intake
No Reference
Yes 0.073 0.174 0.676 0.930 0.661e1.308
Milk intake
No Reference
Yes 0.190 0.150 0.206 1.210 0.901e1.624
Teeth brushing
No Reference
In themorning and
prior to sleep
0.288 0.621 0.642 1.334 0.395e4.505
In the morning,
after meals and
prior to sleep
0.188 0.630 0.766 1.207 0.351e4.145
ALT ¼ alanine aminotransferase; MetS ¼ metabolic syndrome.
Fig. 2. Comparison of free-from-MetS status among patients with and without
proteinuria. Patients with proteinuria were more likely to develop MetS.
MetS ¼ metabolic syndrome.
Yi-H. Lin et al.94For hypertensive African Americans, individuals with MetS had
greater levels of proteinuria23. Patients with MetS were exposed to
higher risk of chronic kidney disease24. The pathogenesis of renal
injury in patients with MetS was related to hyperinsulinemia,
activation of renineangiotensinealdosterone system, increase of
oxidative stress, and inﬂammatory cytokines25. Our results did not
show a positive correlation between serum creatinine level and
new-developed MetS. It might be because proteinuria was a more
sensitive indicator of early renal damage than serum creatinine26.
The coexistence of early chronic kidney disease and MetS increased
the accuracy of risk prediction for cardiovascular disease
mortality27. Because MetS-associated renal injury may predict the
subsequent cardiovascular disease and mortality, further studies to
establish a therapeutic guideline for MetS with renal outcomes as
primary end points are needed27,28.
Our results did not show a signiﬁcant gender difference in the
development of MetS among the elderly population. However,
a previous study of Italian elderly reported that females developed
MetSmore frequently thanmales (300 of 1174men and 835 of 1736
women)29. Menopause, an independent risk factor of MetS for
women, may be responsible for the gender difference30. Lin et al31
reported that there was a signiﬁcant synergistic interaction
between insulin resistance and menopause on the components ofFig. 3. Comparison of free-from-MetS status among patients with different initial
MetS scores. Patients with higher initial MetS scores were more likely to develop MetS.
MetS ¼ metabolic syndrome.MetS, including systolic blood pressure, diastolic blood pressure,
and waist circumference among nondiabetic Chinese women.
Without the protection of female sex hormones, postmenopausal
women might pay more attention to the occurrence of MetS32.
In our results, therewere different rates of new-developed MetS
among elderly in different age groups. Lee et al33 demonstrated
a trend of continuous decrease in MetS with increase in age in
males older than 65 years and females older than 80 years. Park
et al11 found that the prevalence of MetS reached a peak at ages
50e70 years for men and 60e80 years for women in the United
States. Although in our study the effect of agewas insigniﬁcant after
adjusting other factors including gender, blood pressure, serum
creatinine, ALT, uric acid, urine protein, initial MetS score, smoking,
alcohol drinking, exercise, teeth brushing, vegetable intake, and
milk intake, our results showed that patients aged 75e84 years had
an increased risk of developing MetS than those aged 65e74 years.
We found a higher percentage of hyperuricemia among the
elderly with newly developed MetS, but the effect of uric acid was
insigniﬁcant in regression analysis. Previous study had ever re-
ported a positive association between serum uric acid level and
MetS34. Choi and Ford35 reported an elevated prevalence of MetS
with increasing levels of serum uric acid levels. Hyperuricemia was
usually associated with metabolic disorder, such as dyslipidemia
and insulin resistance36. Previous research found a higher preva-
lence of general and abdominal obesity, hypertension, hyper-
triglyceridemia, low HDL, smokers, MetS, and insulin resistance in
patients with hyperuricemia37. Serum uric acid is not just an
innocent bystander in MetS, but it is strongly interrelated with
metabolic disarrangements of MetS38. The associationmight be due
to endothelial dysfunction, and the inﬂammatory and oxidative
changes of hyperuricemia and MetS39,40. Elevated serum uric acid
level could worsen insulin resistance and be associated with
hypertension, dyslipidemia, nonalcoholic fatty liver disease, and
chronic kidney disease, thus increasing the risk of cardiovascular
diseases38.
We found that the elderly who exercise more than three times
a week were less likely to develop MetS. But the protective effect
was unremarkable in the regression model after adjusting for age,
gender, serum creatinine, ALT, uric acid, urine protein, and initial
MetS score, along with other health behaviors. Exercise had been
proved to be a protective factor of MetS, especially for the waist
circumference, blood pressure, and serum TG levels41. Kemmler and
his colleagues42 found that older women under complex high-
intensity aerobic and resistance exercise programs had markedly
improved serum TG and HDL-C levels than their low-intensity
physical activities. Hahn et al43 also reported that sports activities
performed regularly for1 hour and>2 hours per week all reduced
the risks of having MetS for both elder females and males, but
activities such as walking and cycling did not have an additional
inﬂuence. Therefore, exercise intensity was an important factor for
improving aerobic capacity and reversing the risk factors of MetS44.
To achieve health beneﬁts, most older adults were recommended to
participate in at least 150 minutes of moderate-intensity aerobic
activity, 75 minutes of vigorous-intensity aerobic activity, or an
equivalent combination of each per week45. In our study, inability
to deﬁne the intensity of exercise more precisely might be the
reason for the failure to demonstrate the correlation of exercise to
MetS after adjusting for other factors. However, the beneﬁts of
intensive activities and the risks of fall among elderly should be
balanced, especially for those with high risk of falls. The exercise
prescription should be individualized according to a patient’s
health needs and should proceed in an orderly way46. Further
researches with beneﬁts and risks consideration to set feasible
intensity of exercise for the elderly population are particularly
important.
Metabolic Syndrome in Community-Dwelling Elderly 95Our study could not demonstrate a signiﬁcant relationship
between MetS and different health behaviors, including alcohol
drinking, teeth brushing, vegetable intake, and milk intake.
However, in previous studies, lower intake of calcium, milk, and
dairy products had been reported to increase the risk of
MetS11,12,14. Optimal alcohol consumption could reduce the
development of MetS11,47. Slight and moderate alcohol consump-
tion has been found to increase the level of HDL-C and decrease
the risk of coronary heart disease48. The occurrence of MetS
lowered under alcohol intake of <40 g/d in men and 20 g/d in
women47, but excessive wine consumption (50.0 g/d) may raise
the risk of MetS49,50. Smoking was also not proved to be related
with the occurrence of MetS in our study. Nevertheless, a previous
report showed that neither a current smoker nor a former smoker
had higher TG level, lower HDL-C level, and higher risk of devel-
opment of MetS14.
Our study had an inherent limitation. The study population
included the older adults who joined the annual health checkup
and screen in one medical center. Therefore, our results could only
be generalized to community-dwelling elderly who received health
checkup. However, the study participants were the ambulatory
elderly from the Taipei city, the biggest city in Taiwan, and our
results were still representative to provide information on char-
acteristics of baseline demographics, health status, and health
behaviors of newly developed MetS among community-dwelling
elderly in Taiwan. This study could contribute to the discussion of
MetS for the elderly population.
In conclusion, we found that proteinuria and initial MetS score
of 2 were signiﬁcant risk factors of new-developed MetS among
community-dwelling older people. BecauseMetS in the elderly was
associated with the risk of cardiovascular morbidities and
mortality, further studies are needed to establish preventive
strategies and appropriate therapeutic goal for MetS among the
elderly population.References
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